IQVIA Holdings Income After Taxes 2011-2024 | IQV
IQVIA Holdings annual/quarterly income after taxes history and growth rate from 2011 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
- IQVIA Holdings income after taxes for the quarter ending December 31, 2024 was $432M, a 9.05% decline year-over-year.
- IQVIA Holdings income after taxes for the twelve months ending December 31, 2024 was $1.368B, a 0.74% increase year-over-year.
- IQVIA Holdings annual income after taxes for 2024 was $1.368B, a 0.74% increase from 2023.
- IQVIA Holdings annual income after taxes for 2023 was $1.358B, a 23.12% increase from 2022.
- IQVIA Holdings annual income after taxes for 2022 was $1.103B, a 14.3% increase from 2021.
| IQVIA Holdings Annual Income After Taxes (Millions of US $) |
|
|---|---|
| 2024 | $1,368 |
| 2023 | $1,358 |
| 2022 | $1,103 |
| 2021 | $965 |
| 2020 | $301 |
| 2019 | $236 |
| 2018 | $269 |
| 2017 | $1,286 |
| 2016 | $91 |
| 2015 | $380 |
| 2014 | $352 |
| 2013 | $227 |
| 2012 | $174 |
| 2011 | $170 |
| 2010 | $164 |
| IQVIA Holdings Quarterly Income After Taxes (Millions of US $) |
|
|---|---|
| 2024-12-31 | $432 |
| 2024-09-30 | $284 |
| 2024-06-30 | $361 |
| 2024-03-31 | $291 |
| 2023-12-31 | $475 |
| 2023-09-30 | $298 |
| 2023-06-30 | $294 |
| 2023-03-31 | $291 |
| 2022-12-31 | $227 |
| 2022-09-30 | $290 |
| 2022-06-30 | $257 |
| 2022-03-31 | $329 |
| 2021-12-31 | $317 |
| 2021-09-30 | $261 |
| 2021-06-30 | $174 |
| 2021-03-31 | $213 |
| 2020-12-31 | $131 |
| 2020-09-30 | $105 |
| 2020-06-30 | $-20 |
| 2020-03-31 | $85 |
| 2019-12-31 | $28 |
| 2019-09-30 | $70 |
| 2019-06-30 | $70 |
| 2019-03-31 | $68 |
| 2018-12-31 | $74 |
| 2018-09-30 | $65 |
| 2018-06-30 | $64 |
| 2018-03-31 | $66 |
| 2017-12-31 | $1,032 |
| 2017-09-30 | $89 |
| 2017-06-30 | $62 |
| 2017-03-31 | $103 |
| 2016-12-31 | $-214 |
| 2016-09-30 | $104 |
| 2016-06-30 | $95 |
| 2016-03-31 | $106 |
| 2015-12-31 | $108 |
| 2015-09-30 | $103 |
| 2015-06-30 | $83 |
| 2015-03-31 | $86 |
| 2014-12-31 | $94 |
| 2014-09-30 | $91 |
| 2014-06-30 | $82 |
| 2014-03-31 | $85 |
| 2013-12-31 | $72 |
| 2013-09-30 | $67 |
| 2013-06-30 | $38 |
| 2013-03-31 | $50 |
| 2012-12-31 | $35 |
| 2012-09-30 | $51 |
| 2012-06-30 | $47 |
| 2012-03-31 | $41 |
| 2011-12-31 | |
| 2010-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $25.374B | $15.405B |
| IQVIA Holdings Inc. provides advanced analytics, technology solutions and contract research services to the life sciences industry. The company was formed through the merger of IMS Health (RX) and Quintiles. The company is focused on helping healthcare clients to better serve patients by bringing in updated and innovative ideas in the process of clinical development and commercialization, speed innovation and accelerate improvements. I | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $171.942B | 78.88 |
| Thermo Fisher Scientific (TMO) | United States | $161.378B | 19.56 |
| Alcon (ALC) | Switzerland | $45.645B | 30.34 |
| Edwards Lifesciences (EW) | United States | $42.050B | 27.30 |
| IDEXX Laboratories (IDXX) | United States | $33.347B | 38.56 |
| DexCom (DXCM) | United States | $26.887B | 41.56 |
| STERIS (STE) | Ireland | $21.834B | 24.97 |
| Mettler-Toledo (MTD) | United States | $20.944B | 24.42 |
| Waters (WAT) | United States | $19.099B | 27.04 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.304B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.878B | 14.16 |
| Hologic (HOLX) | United States | $12.916B | 13.94 |
| Sysmex ADR (SSMXY) | Japan | $11.847B | 0.00 |
| Penumbra (PEN) | United States | $10.729B | 96.64 |
| Globus Medical (GMED) | United States | $9.767B | 22.61 |
| Masimo (MASI) | United States | $8.221B | 34.50 |
| Teleflex (TFX) | United States | $6.004B | 9.24 |
| Glaukos (GKOS) | United States | $5.153B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.081B | 22.07 |
| TransMedics (TMDX) | United States | $2.985B | 87.37 |
| PROCEPT BioRobotics (PRCT) | United States | $2.907B | 0.00 |
| Veracyte (VCYT) | United States | $2.427B | 43.86 |
| Nihon Kohden (NHNKY) | Japan | $2.081B | 11.37 |
| LivaNova (LIVN) | United Kingdom | $1.934B | 11.74 |
| Elekta AB (EKTAY) | Sweden | $1.891B | 17.00 |
| Alphatec Holdings (ATEC) | United States | $1.522B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.222B | 6.18 |
| Pulse Biosciences (PLSE) | United States | $1.193B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.122B | 0.00 |
| Paragon 28 (FNA) | United States | $1.099B | 0.00 |
| Artivion (AORT) | United States | $0.979B | 91.72 |
| OPKO Health (OPK) | United States | $0.954B | 0.00 |
| AxoGen (AXGN) | United States | $0.690B | 0.00 |
| IRadimed (IRMD) | United States | $0.658B | 34.51 |
| Mesa Laboratories (MLAB) | United States | $0.609B | 13.30 |
| SiBone (SIBN) | United States | $0.588B | 0.00 |
| RxSight (RXST) | United States | $0.584B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.572B | 9.21 |
| OrthoPediatrics (KIDS) | United States | $0.510B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.508B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.483B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.406B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.389B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.387B | 0.00 |
| NeuroPace (NPCE) | United States | $0.351B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.348B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.342B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.315B | 16.87 |
| Semler Scientific (SMLR) | United States | $0.312B | 6.62 |
| Neuronetics (STIM) | United States | $0.247B | 0.00 |
| Inogen (INGN) | United States | $0.183B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.181B | 0.00 |
| 908 Devices (MASS) | United States | $0.168B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.165B | 0.00 |
| LENSAR (LNSR) | United States | $0.164B | 0.00 |
| CVRx (CVRX) | United States | $0.163B | 0.00 |
| Accuray (ARAY) | United States | $0.152B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.137B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.110B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.104B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.104B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.104B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.095B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.087B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.080B | 0.00 |
| InspireMD (NSPR) | Israel | $0.079B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.076B | 11.48 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.051B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.043B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.037B | 0.00 | |
| Vicarious Surgical (RBOT) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Precision Optics (POCI) | United States | $0.030B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.022B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.014B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |